Observational studyAdvances in respiratory medicine2024

Successful Therapy over 12 Months of People with Cystic Fibrosis with Rare Non-phe508del Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations with Elexacaftor/Tezacaftor/Ivacaftor (ETI).

Tomke Sütering et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.